Search results
Beckman Coulter receives FDA warning letter
MedTech Dive via Yahoo Finance· 2 months agoDive Brief: Beckman Coulter received a warning letter in March after inspectors found fault with quality practices at a facility that makes immunoassay...
Reasons Why Danaher (DHR) Should be in Your Portfolio Now
Zacks via Yahoo Finance· 2 months agoDanaher Corporation DHR is well poised for growth courtesy of strength across its end markets,...
Danaher names Martin Stumpe as chief data and AI officer
MedTech Dive via Yahoo Finance· 1 week agoName: Martin Stumpe New title: Chief Data and Artificial Intelligence Officer, Danaher Previous...
Hematology Analyzer Market Booming With Rising Demands and Massive Opportunities, 2023 - 2028
NewMediaWire via Yahoo Finance· 1 year agoPune, India - (NewMediaWire) - March 2, 2023 - Hematology Analyzer Market | Outlook 2023-2028 | Pre...
Danaher (DHR) Up 14% in 6 Months: What's Driving the Stock?
Zacks via Yahoo Finance· 1 year agoDanaher (DHR) gains from strength across its core Life Sciences segment, benefits from the DBS...
Here's How Much a $1000 Investment in Danaher Made 10 Years Ago Would Be Worth Today
Zacks via Yahoo Finance· 2 years agoHow much a stock's price changes over time is important for most investors, since price performance...
Earnings Today: PulteGroup, Danaher Rally; JetBlue Dives
Investor's Business Daily· 2 months agoBig earnings movers early Tuesday included GE Aerospace, General Motors and UPS. PulteGroup, Danaher...
Here's Why You Should Hold on to Danaher (DHR) Stock Now
Zacks via Yahoo Finance· 1 year agoThe DBS initiatives, cost management actions and steady demand across major end markets augur well...
3 Large-Cap Biotech Stocks to Hold for the Long Haul
InvestorPlace via Yahoo Finance· 1 year agoDespite the sharp slide in biotech stocks during 2022, the industry is still poised for mega growth. Pandemic preparedness needs better vaccines and...
Danaher (DHR) Gears Up to Post Q1 Earnings: Is a Beat Likely?
Zacks via Yahoo Finance· 2 months agoDanaher's (DHR) Q1 earnings are likely to be hurt by weakness in the Biotechnology unit. Improving...